CytoReasonCytoReason
CytoReason

CytoReason

Develops a computational model of the human body for drug discovery and development.

2016Active116

About

CytoReason builds comprehensive computational disease models to map disease and drug mechanisms. Their platform enables pharmaceutical and biotech companies to manage drug portfolios, prioritize programs, and compare treatments across patient populations by integrating human data for predictable drug development. This allows scientists to gain deep drug profiles and executives to have a bird's-eye view of their entire portfolio.

Technology stack

detected 2026-06-18
Est. monthly stack spend~$1,110/mo
EmailMicrosoft 365
Hosting
Hetzner
Stack
jQueryWordPress
Analytics
Google Analytics 4
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does CytoReason do?

CytoReason builds comprehensive computational disease models to map disease and drug mechanisms. Their platform enables pharmaceutical and biotech companies to manage drug portfolios, prioritize programs, and compare treatments across patient populations by integrating human data for predictable drug development. This allows scientists to gain deep drug profiles and executives to have a bird's-eye view of their entire portfolio.

How much funding has CytoReason raised?

CytoReason has raised a total of $128M in funding. The most recent round on record is Series B.

Where is CytoReason headquartered?

CytoReason is headquartered in Tel Aviv, Israel.

When was CytoReason founded?

CytoReason was founded in 2016.

What industry does CytoReason operate in?

CytoReason operates in Healthcare, Drug Discovery, Clinical Development, Biomarkers, Target Discovery, Combination Selection.

How many employees does CytoReason have?

CytoReason has approximately 116 people on record.